What is Alzheimer’s disease?

    Researchedby:

    Fact-checked

    by:

    Last Updated: October 13, 2024

    Alzheimer’s disease is a form of dementia, a general term for neurological conditions that impair cognitive function to the point of interfering with daily life. It is the most common type of dementia (representing around 60 to 80% of cases) and involves a progressive degeneration of brain cells. Alzheimer’s disease is currently the fifth-leading cause of death for people older than 65 in the United States.[1]

    Alzheimer’s disease is a neurological disorder involving cognitive and functional impairments that almost always worsen with time. The disease is typically first identified by memory loss and forgetfulness, with episodic (personal experiences and events) and semantic (facts and words) memory usually impaired first. Short-term memory also becomes limited, with a smaller capacity and shorter duration. Procedural memory — how to perform functions and tasks — is not affected until much later.[2][3]

    As the disease progresses and different areas of the brain degenerate, additional symptoms develop, including mood changes, difficulty with language, trouble performing basic activities, and, in later stages, an impaired ability to swallow and breathe.

    Prior to developing Alzheimer’s disease, individuals first develop a less extreme disorder called mild cognitive impairment (MCI). Although MCI is common during older age (a time when cognitive function declines to some extent), with Alzheimer’s disease, memory problems exceed what is expected based on age. Despite MCI being a risk factor, people who develop the disorder don’t usually progress to Alzheimer’s disease[4], and there does not seem to be evidence that screening older adults for early MCI is beneficial.[5]

    Once a person is diagnosed with Alzheimer’s disease, the progression of cognitive decline is about a 3-point reduction per year on the 30-point Mini–Mental State Examination (MMSE).[6][7]

    References

    1. ^2021 Alzheimer's disease facts and figuresAlzheimers Dement.(2021 Mar)
    2. ^Jahn HMemory loss in Alzheimer's disease.Dialogues Clin Neurosci.(2013-Dec)
    3. ^Mortamais M, Ash JA, Harrison J, Kaye J, Kramer J, Randolph C, Pose C, Albala B, Ropacki M, Ritchie CW, Ritchie KDetecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.Alzheimers Dement.(2017-Apr)
    4. ^Mitchell AJ, Shiri-Feshki MRate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.Acta Psychiatr Scand.(2009-Apr)
    5. ^Carrie D. Patnode, Leslie A. Perdue, Rebecca C. Rossom, Megan C. Rushkin, Nadia Redmond, Rachel G. Thomas, Jennifer S. LinScreening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force Internet
    6. ^Han L, Cole M, Bellavance F, McCusker J, Primeau FTracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis.Int Psychogeriatr.(2000-Jun)
    7. ^Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, Mohs R, Heyman AVariability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease.Arch Neurol.(1999-Jul)